Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries

BACKGROUND: Tafenoquine is a long half-life primaquine analog being developed for malaria prophylaxis. The US Army recently performed a unified analysis of efficacy in preparation for a regulatory submission, utilizing legacy data from three placebo-controlled studies conducted in the late 1990s and...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Malar J
Главные авторы: Dow, Geoffrey S., Liu, Jun, Lin, Gina, Hetzell, Brian, Thieling, Sarah, McCarthy, William F., Tang, Douglas, Smith, Bryan
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4661991/
https://ncbi.nlm.nih.gov/pubmed/26610844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0991-x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы